Fortrea Holdings Inc. has grown revenue −0.09% a year over three years and −2.9% a year over five. Revenue growth, 3-year annual rate: −0.09% (Biotechnology median +17%). Revenue growth, 5-year rate: −2.9%, growth has picked up over the last three years. Years of annual history on file: 5, FY2021 to FY2025, as filed.

FTREFortrea Holdings Inc.

Healthcare

$20.85+106% 1Y

$20.85

$8.4052 weeks$21.12

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+33.8 points), but revenue shrinking (−2% year on year).

1 good, 1 to watch, 1 without data

Revenue trend−2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+33.8 points operating

Trailing-twelve-month operating margin, -0.4% now against -34.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 79% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is FTRE growing?

Fortrea Holdings Inc. has grown revenue −0.09% a year over three years and −2.9% a year over five.

−0.09%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −2.9%
Revenue growth, 5-year rate · −0.09% over three · growth has picked up over the last three years
Years of annual history on file: 5
Years of annual history on file · FY2021 to FY2025, as filed

Details›